‘Second Lab Leak’ from Pfizer’s India Operations?

As the world continues to grapple with the ongoing COVID-19 pandemic, fresh questions have emerged about the origin of the virus and whether one of its more pathogenic variants, Delta, may have originated from Pfizer Inc.’s India operations.

New undercover footage released by Project Veritas has added fuel to the fire, with a Pfizer executive claiming that his company was exploring ways to “mutate” the coronavirus via “directed evolution.” The video, which was recorded by a Project Veritas undercover journalist, features Dr. Jordon Trishton Walker, a medical doctor who graduated from Yale and the University of Texas Southwestern. In a stunning admission, Pfizer’s Dr. Walker reveals that scientists working for his company were “optimizing” the coronavirus’ mutation process by putting “the virus in monkeys.”

Pfizer announced back in September 2020 that it was conducting COVID-19-related studies with macaque monkeys. Less than a month later, the Delta variant of the virus was discovered in Maharashtra, India. Pfizer has been operating in India since 1950, with its headquarters in Mumbai, a densely populated city also located in the state of Maharashtra. Dr. NK Arora, co-chair of the ‘Indian SARS-CoV-2 Genomics Consortium’ (INSACOG), at the time announced that Delta “emerged in Maharashtra and traveled northwards along the western states of the country before entering the central and the eastern states.”

The Delta variant was discovered to be “twice as contagious” as initial COVID variants and more likely to “put infected people in the hospital.” The new information from Dr. Walker has raised serious questions about the origin of the Delta variant, and whether it may have been the result of experiments conducted by Pfizer in India.

In May 2020, seven months before India’s Delta outbreak, a group of macaque monkeys reportedly attacked a laboratory assistant in Delhi and escaped with a number of coronavirus blood samples. The monkeys “snatched Covid-19 blood samples from four patients and fled the facilities near the Meerut Medical College in Delhi.” One of the monkeys was spotted in a tree “chewing one of the sample collection kits.” Dr. S. K. Garg, a top official at the college, said the monkeys “grabbed and fled with the blood samples of four Covid-19 patients.”

Two studies published in the U.S. National Library of Medicine (NLM) link COVID-related monkey research and Pfizer to the city of Meerut:

A November 2020 publication in Human Vaccines & Immunotherapeutics analyzed “recent advances in recombinant COVID-19 vaccine research,” including into macaque monkeys, coronavirus, and Pfizer’s mRNA vaccine. One of the study authors, Dr. Gourav Mishra, is affiliated with the Department of Biotechnology at the Meerut Institute of Engineering and Technology (MIET) in the city of Meerut, where monkeys “snatched” COVID blood samples. Dr. Mishra’s LinkedIn page indicates he worked directly for Pfizer from 2011 to 2012. Another author, Dr. Nishant Srivastava, is also affiliated with MIET.

An earlier study published in April 2020—six months before Delta’s outbreak in India—also analyzed research into macaques, COVID, and Pfizer’s mRNA jab. The study was authored by Dr. Nishant Srivastava, who is also affiliated with MIET. Dr. Srivastava’s LinkedIn page says he is “Medical lead for COVID-19 and mRNA vaccines at Pfizer Emerging Markets.” Moreover, Srivastava is “Vaccine development lead at [the] Bill & Melinda Gates Foundation” and an “alum” of the Boston Consulting Group (BCG), where Dr. Walker, from the Project Veritas investigation, was also employed. Srivastava is “experienced in biopharma R&D & corporate growth strategy, M&A and commercialization,” has “20+ years research experience in vaccines, infectious disease, cell biology and diagnostics development,” and is funded by the U.S. National Institutes of Health and the Gates Foundation, according to his LinkedIn profile.

Pfizer has yet to respond to the allegations made in the video, but the company has a decades-long history of operating in India, with three manufacturing plants, two research and development centers, and six regional centers for commercial operations and global support functions in the country. The pharmaceutical giant represents the fourth-largest multinational pharmaceutical company in India.

The possibility that the COVID pandemic began with a “leak” from the Wuhan Institute of Virology has gained worldwide attention. The possibility of a second lab leak from Pfizer’s India operations will be a controversial topic in the scientific community. Nevertheless, the new information revealed in the Project Veritas video has reignited the debate and has many calling for further investigation into the origin of the Delta variant.